Skip to main content
. Author manuscript; available in PMC: 2020 Jan 1.
Published in final edited form as: Int J Hyperthermia. 2019;36(1):817–826. doi: 10.1080/02656736.2019.1642521

Figure 6. Fluorescence intensity predicts drug delivered to tumors.

Figure 6.

The mean fluorescence in the tumor ROI measured after hyperthermia conclusion was predictive of the concentration of doxorubicin delivered to tumors (p=0.002).